Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxytocin-induced uterine contraction refers to the process by which the hormone oxytocin stimulates contractions of the uterus, primarily during labor and childbirth. Oxytocin binds to its receptor (OTR) on myometrial cells, activating the Gq/PLC/IP3 pathway, leading to increased intracellular calcium and muscle contraction. It is clinically relevant for labor induction/augmentation and postpartum hemorrhage management.
Oxytocin binds to the oxytocin receptor (OTR), a Gq-coupled receptor, leading to increased intracellular calcium levels and myometrial contraction.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxytocin-Induced Uterine Contraction (None).